nifedipine has been researched along with 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (58.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, N; Gougoutas, J; Hedberg, A; Kimball, SD; Malley, M; Moreland, S; Porubcan, M; Pudzianowski, A; Rovnyak, G | 1 |
| Coburn, RA; Solo, AJ; Suto, MJ; Triggle, AM; Triggle, DJ; Wierzba, M | 1 |
| Dagnino, L; Knaus, EE; Li-Kwong-Ken, MC; Triggle, CR; Wolowyk, MW; Wynn, H | 1 |
| Fossheim, R; Mostad, A; Rømming, C; Shefter, E; Svarteng, K; Triggle, DJ | 1 |
| Cena, C; Di Stilo, A; Ermondi, G; Gasco, A; Gasco, AM; Visentin, S | 1 |
| Schleifer, KJ | 1 |
| Born, L; Goldmann, S; Kazda, S; Pittel, B; Schramm, M | 1 |
| Rao, MR | 1 |
| Liang, MD; Liu, F; Rao, MR; Shen, XH; Zou, X | 1 |
| Liang, MD; Liu, F; Liu, GY; Rao, MR; Zhang, HQ | 1 |
| Himmel, HM; Ravens, U; Stengel, W | 1 |
| Liu, XY; Mei, QB; Yang, TH; Yang, ZF; Zhou, SY | 1 |
12 other study(ies) available for nifedipine and 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester
| Article | Year |
|---|---|
Studies directed toward ascertaining the active conformation of 1,4-dihydropyridine calcium entry blockers.
Topics: Animals; Binding, Competitive; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Guinea Pigs; In Vitro Techniques; Models, Molecular; Molecular Conformation; Muscle Relaxation; Muscle, Smooth, Vascular; Nifedipine; Rabbits; Radioligand Assay; Receptors, Nicotinic; Structure-Activity Relationship | 1988 |
1,4-Dihydropyridine antagonist activities at the calcium channel: a quantitative structure-activity relationship approach.
Topics: Animals; Calcium Channels; Dihydropyridines; Guinea Pigs; In Vitro Techniques; Mathematics; Muscle Contraction; Structure-Activity Relationship | 1988 |
Synthesis and calcium channel antagonist activity of dialkyl 4- (dihydropyridinyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinecarboxylates.
Topics: Animals; Calcium Channel Blockers; Chemical Phenomena; Chemistry; Dicarboxylic Acids; Guinea Pigs; Male; Muscle Contraction; Muscle, Smooth; Pyridines; Receptors, Muscarinic; Structure-Activity Relationship | 1987 |
Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 2-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridine.
Topics: Calcium Channel Blockers; Chemical Phenomena; Chemistry; Dihydropyridines; Models, Molecular; Molecular Conformation; Nifedipine; Phosphorylcholine; Pyridines; Structure-Activity Relationship; X-Ray Diffraction | 1982 |
New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities.
Topics: Animals; Aorta, Thoracic; Binding, Competitive; Calcium Channel Blockers; Cerebral Cortex; Dihydropyridines; Enzyme Inhibitors; Guanylate Cyclase; In Vitro Techniques; Male; Methylene Blue; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Nitric Oxide Donors; Oxadiazoles; Quinoxalines; Radioligand Assay; Rats; Rats, Wistar; Structure-Activity Relationship; Vasodilator Agents | 1998 |
Stereoselective characterization of the 1,4-dihydropyridine binding site at L-type calcium channels in the resting state and the opened/inactivated state.
Topics: Binding Sites; Calcium Channels; Calcium Channels, L-Type; Dihydropyridines; Ion Channel Gating; Models, Molecular; Molecular Conformation; Stereoisomerism | 1999 |
Synthesis, pharmacological effects, and conformation of 4,4-disubstituted 1,4-dihydropyridines.
Topics: Animals; Antihypertensive Agents; Chemical Phenomena; Chemistry; Dihydropyridines; Dogs; Models, Molecular; Molecular Conformation; Muscle, Smooth, Vascular; Nifedipine; Rabbits | 1990 |
[Comparative studies on the antihypertensive effects of m-nifedipine, nifedipine and nitrendipine in conscious rats and rabbits].
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Hypertension, Renovascular; Male; Nifedipine; Nitrendipine; Rabbits; Rats; Rats, Inbred Strains | 1987 |
[Effects of M-nifedipine on contractile responses in isolated atria and coronary vessels: a comparison with nifedipine].
Topics: Animals; Calcium Channel Blockers; Coronary Vessels; Dose-Response Relationship, Drug; Guinea Pigs; In Vitro Techniques; Muscle Contraction; Myocardial Contraction; Nifedipine; Vasodilator Agents | 1986 |
[Effect of m-nifedipine, a calcium antagonist, on cardiac performance and oxygen consumption in anesthetized animal: a comparison with nifedipine].
Topics: Animals; Calcium Channel Blockers; Carbon Dioxide; Cats; Dogs; Heart; Myocardium; Nifedipine; Oxygen Consumption; Rabbits | 1984 |
Selectivity of blocking of low- versus high-voltage activated calcium currents by the dihydropyridine derivatives Bay E5759 and Bay A4339 in neuroblastoma--glioma NG 108-15 cells.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Dose-Response Relationship, Drug; Electrophysiology; Hybrid Cells; Mibefradil; Mice; Nifedipine; Nisoldipine; Rats; Tumor Cells, Cultured | 2001 |
Pharmacokinetics of the analogs at C3 and C5 of m-nifedipine in beagle dogs.
Topics: Animals; Area Under Curve; Dogs; Male; Molecular Structure; Nifedipine; Reproducibility of Results | 2008 |